Chemoprevention of oral cancer in animal models, and effect on leukoplakias in human patients with ZengShengPing, a mixture of medicinal herbs

Oral Oncology

Volumn 46, Issue 2, 2010, Pages 105-110

  Sun, Zheng ^a   Guan, Xiaobing ^a   Li, Ning ^b   Liu, Xiaoyong ^a   Chen, Xiaoxin ^a,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

Chemoprevention; Oral cancer; Oral leukoplakia; ZengShengPing

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CYCLINE; HERBACEOUS AGENT; PLACEBO; UNCLASSIFIED DRUG; ZENGSHENGPING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHEEK POUCH; CHEMOPROPHYLAXIS; CHROMOSOME NOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS CANCER; FEMALE; HAMSTER; HUMAN; INCIDENCE; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUSE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR VOLUME;

ADULT; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHEEK; CRICETINAE; FEMALE; HUMANS; LEUKOPLAKIA; MALE; MICE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PLANTS, MEDICINAL;

EID: 74649086130     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.06.004     Document Type: Article

References (41)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 58 2 (2008) 71-96
2. Zhang Z., Wang Y., Yao R., Li J., Yan Y., Regina M., et al. Cancer chemopreventive activity of a mixture of Chinese herbs in mouse lung tumor models. Oncogene 23 (2004) 3841-3850
3. Kanojia D., and Vaidya M.M. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol 42 7 (2006) 655-667
4. Schwartz J., and Gu X. Hamster oral cancer model. In: Teicher B.A. (Ed). Tumor models in cancer research (2001), Humana Press Inc., Totowa, NJ 141-172
5. Li N., Chen X., Liao J., Yang G., Wang S., Josephson Y., et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23 8 (2002) 1307-1313
6. Li N., Sood S., Wang S., Fang M., Wang P., Sun Z., et al. Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib. Clin Cancer Res 11 5 (2005) 2089-2096
7. Silverman S, editor. Oral cancer. 5th ed. Hamilton: BC Decker; 2003.
8. Ploton D., Menager M., Jeannesson P., Himber G., Pigeon F., and Adnet J.J. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18 1 (1986) 5-14
9. Wang D., Wang D., Zhang J., Zhang J., Wang Y., Zhang L., et al. Experimental study on the pharmacologic effects of Zeng Sheng Ping. Chin J Oncol 16 6 (1994) 419-423
10. Sun Z., Sood S., Li N., Ramji D., Yang P., Newman R.A., et al. Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors. Carcinogenesis 27 9 (2006) 1902-1908
11. Psotova J., Kolar M., Sousek J., Svagera Z., Vicar J., and Ulrichova J. Biological activities of Prunella vulgaris extract. Phytother Res 17 9 (2003) 1082-1087
12. Snijders A.M., Schmidt B.L., Fridlyand J., Dekker N., Pinkel D., Jordan R.C., et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24 26 (2005) 4232-4242
13. Leethanakul C., Patel V., Gillespie J., Pallente M., Ensley J.F., Koontongkaew S., et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19 28 (2000) 3220-3224
14. Zeng Q., Li S., Chepeha D.B., Giordano T.J., Li J., Zhang H., et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8 1 (2005) 13-23
15. Gao G., and Law F.C. Physiologically based pharmacokinetics of matrine in the rat after oral administration of pure chemical and ACAPHA. Drug Metab Dispos 37 4 (2009) 884-891
16. Gao G. Comparative pharmacokinetics of matrine: pure matrine vs crude chemical in ACAPHA (2007), Simon Fraser University, Burnaby, British Columbia, Canada
17. Duwiejua M., Zeitlin I.J., Gray A.I., and Waterman P.G. The anti-inflammatory compounds of Polygonum bistorta: isolation and characterisation. Planta Med 65 4 (1999) 371-374
18. Manoharan K.P., Yang D., Hsu A., and Huat B.T. Evaluation of Polygonum bistorta for anticancer potential using selected cancer cell lines. Med Chem 3 2 (2007) 121-126
19. Kim S.Y., Kim S.H., Shin H.Y., Lim J.P., Chae B.S., Park J.S., et al. Effects of Prunella vulgaris on mast cell-mediated allergic reaction and inflammatory cytokine production. Exp Biol Med (Maywood) 232 7 (2007) 921-926
20. Ryu S.Y., Oak M.H., Yoon S.K., Cho D.I., Yoo G.S., Kim T.S., et al. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med 66 4 (2000) 358-360
21. Lee H., and Lin J.Y. Antimutagenic activity of extracts from anticancer drugs in Chinese medicine. Mutat Res 204 2 (1988) 229-234
22. Zdarilova A., Svobodova A., Simanek V., and Ulrichova J. Prunella vulgaris extract and rosmarinic acid suppress lipopolysaccharide-induced alteration in human gingival fibroblasts. Toxicol In Vitro 23 3 (2009) 386-392
23. Jeong G.S., An R.B., Pae H.O., Oh G.S., Chung H.T., and Kim Y.C. Heme oxygenase-1 inducing constituent of Prunella vulgaris in HepG2 cells. Biol Pharm Bull 31 3 (2008) 531-533
24. Jiang S., Nakano Y., Rahman M.A., Yatsuzuka R., and Kamei C. Effects of a Dictamnus dasycarpus T. extract on allergic models in mice. Biosci Biotechnol Biochem 72 3 (2008) 660-665
25. Chang J., Xuan L.J., Xu Y.M., and Zhang J.S. Cytotoxic terpenoid and immunosuppressive phenolic glycosides from the root bark of Dictamnus dasycarpus. Planta Med 68 5 (2002) 425-429
26. Gao H., Kuroyanagi M., Wu L., Kawahara N., Yasuno T., and Nakamura Y. Antitumor-promoting constituents from Dioscorea bulbifera L. in JB6 mouse epidermal cells. Biol Pharm Bull 25 9 (2002) 1241-1243
27. Yu Z.L., Liu X.R., McCulloch M., and Gao J. Anticancer effects of various fractions extracted from Dioscorea bulbifera on mice bearing HepA. Zhongguo Zhong Yao Za Zhi 29 6 (2004) 563-567
28. Jang J.S., Seo E.G., Han C., Chae H.B., Kim S.J., Lee J.D., et al. Four cases of toxic liver injury associated with Dictamnus dasycarpus. Korean J Hepatol 14 2 (2008) 206-212
29. McRae C.A., Agarwal K., Mutimer D., and Bassendine M.F. Hepatitis associated with Chinese herbs. Eur J Gastroenterol Hepatol 14 5 (2002) 559-562
30. Su L., Zhu J.H., and Cheng L.B. Experimental pathological study of subacute intoxication by Dioscorea bulbifera L. Fa Yi Xue Za Zhi 19 2 (2003) 81-83
31. Tan X.Q., Ruan J.L., Chen H.S., and Wang J.Y. Studies on liver-toxicity in rhigoma of Dioscorea bulbifera. Zhongguo Zhong Yao Za Zhi 28 7 (2003) 661-663
32. Smith J., Rattay T., McConkey C., Helliwell T., and Mehanna H. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol 45 8 (2009) 647-653
33. Vairaktaris E., Spyridonidou S., Papakosta V., Vylliotis A., Lazaris A., Perrea D., et al. The hamster model of sequential oral oncogenesis. Oral Oncol 44 4 (2008) 315-324
34. Vered M., Yarom N., and Dayan D. 4NQO oral carcinogenesis: animal models, molecular markers and future expectations. Oral Oncol 41 4 (2005) 337-339
35. Lin P. Medicamentous inhibitory therapy of precancerous lesions of the esophagus - 3 and 5 year inhibitory effect of antitumor B, retinamide and riboflavin. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 12 4 (1990) 235-245
36. Cai HY, Shu YJ, Wang GQ, Wu AR, Lin PZ, Liu SF, et al. Therapy of severe epithelial dysplasia of esophagus. I. Therapeutic effects of Antitumor B III, Antitumor B and tilorone. Zhonghua Zhong Liu Za Zhi 1980;2(2):92-5 [author's transla].
37. Fan J., Zhang J., Xie J., Liu Y., Li T., and Lin P. Inhibitory effect of Antitumor B and retinamide on precancerous lesions of the bladder in rats. Acta Academiae Medicinae Sinicae 15 1 (1993) 71-73
38. Lin P.Z., Zhang J.S., Cao S.G., Rong Z.P., Gao R.Q., Han R., et al. Secondary prevention of esophageal cancer - intervention on precancerous lesions of the esophagus. Zhonghua Zhong Liu Za Zhi 10 3 (1988) 161-166
39. Ding Z., Gao F., and Lin P. Long-term effect of treating patients with precancerous lesions of the esophagus. Zhonghua Zhong Liu Za Zhi 21 4 (1999) 275-277
40. Lin P., Chen Z., Hou J., Liu T., and Wang J. Chemoprevention of esophageal cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 20 6 (1998) 413-418
41. Hou J., Lin P.Z., Chen Z.F., Ding Z.W., Li S.S., Men F.S., et al. Field population-based blocking treatment of esophageal epithelia dysplasia. World J Gastroenterol 8 3 (2002) 418-422